Pasithea Therapeutics Corp. (NASDAQ:KTTA) Sees Large Increase in Short Interest

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 13,500 shares, a growth of 29.8% from the December 31st total of 10,400 shares. Approximately 0.1% of the shares of the stock are short sold. Based […]

Related Keywords

,Vanguard Group Inc ,Pasithea Therapeutics Corp ,Nasdaq ,Pasithea Therapeutics Company Profile ,Pasithea Therapeutics ,Get Free Report ,Free Report ,Therapeutics Corp ,Central Nervous System ,Pasithea Therapeutics Daily ,Nasdaq Ktta ,Ktta ,Medical ,Stocks ,Options ,Put ,Call ,